Nanocrystalline titanium dioxide and magnesium oxide in vitro dermal absorption in human skin

Cutaneous and Ocular Toxicology

Volumn 28, Issue 2, 2009, Pages 78-82

  Merwe, Deon Van Der ^a   Tawde, Snehal ^a   Pickrell, John A ^a   Erickson, Larry E ^b  

^a KANSAS STATE UNIVERSITY   (United States)

^b Sunflower Networking Group   (United States)

Author keywords

Dermal absorption; Magnesium oxide; Metal oxides; Nanocrystalline; Titanium dioxide

Indexed keywords

MAGNESIUM OXIDE; NANOCRYSTALLINE; NANOPARTICLE; SURFACTANT; TITANIUM DIOXIDE; UNCLASSIFIED DRUG; WATER; TITANIUM;

ARTICLE; CLINICAL ASSESSMENT; CONTROLLED STUDY; DERMATOME; DIFFUSION; DRY POWDER; HUMAN; HUMAN TISSUE; IN VITRO STUDY; SKIN ABSORPTION; SKIN SURFACE; STRATUM CORNEUM; SUSPENSION; ADULT; BIOLOGICAL MODEL; BLOOD; CHEMISTRY; DIFFUSION CHAMBER; DRUG EFFECT; METABOLISM; SKIN; TOPICAL DRUG ADMINISTRATION; TRANSMISSION ELECTRON MICROSCOPY; ULTRASTRUCTURE;

ADMINISTRATION, TOPICAL; ADULT; DIFFUSION CHAMBERS, CULTURE; HUMANS; MAGNESIUM OXIDE; MICROSCOPY, ELECTRON, TRANSMISSION; MODELS, BIOLOGICAL; NANOPARTICLES; SKIN; SKIN ABSORPTION; TITANIUM;

EID: 70349768367     PISSN: 15569527     EISSN: 15569535     Source Type: Journal    
DOI: 10.1080/15569520902914926     Document Type: Article

References (10)

1. Bronaugh RL, Stewart RF. Methods for in vitro percutaneous absorption studies V: Permeation through damaged skin. J Pharm Sci. 1985; 74(10): 1062-1066.
2. Potts RO, Guy RH. A predictive algorithm for skin permeability: the effects of molecular size and hydrogen bond activity. Pharm Res. 1995; 12(11): 1628-1633.
3. Cross SE, Innes B, Roberts MS, Tsuzuki T, Robertson TA, McCormick P. Human skin penetration of sunscreen nanoparticles: In-vitro assessment of a novel micronized zinc oxide formulation. Skin Pharmacology and Physiology. 2007; 20(3): 148-154.
4. Lademann J, Weigmann HJ, Rickmeyer C, Barthelmes H, Schaefer H, Mueller G, Sterry W. Penetration of titanium dioxide microparticles in a sunscreen formulation into the horny layer and the follicular orifice. Skin Pharmacol Appl. 1999; 12(5): 247-256.
5. Gamer AO, Leibold E, van Ravenzwaay B. The in vitro absorption of microfine zinc oxide and titanium dioxide through porcine skin. Toxicology in Vitro. 2006; 20(3): 301-307.
6. Zhang LW, Monteiro-Riviere NA. Assessment of Quantum Dot Penetration into Intact, Tape- Stripped, Abraded and Flexed Rat Skin. Skin Pharmacology and Physiology. 2008; 21(3): 166-180.
7. Raykar PV, Fung MC, Anderson BD. The role of protein and lipid domains in the uptake of solutes by human stratum corneum. Pharmaceutical Research. 1988; 5(3): 140-150.
8. Scheuplein RJ, Blank IH. Permeability of the skin. Physiol Rev. 1971; 51(4): 702-747.
9. Van der Merwe D, Brooks JD, Gehring R, Baynes RE, Monteiro- Riviere NA, Riviere JE. A Physiologically Based Pharmacokinetic Model of Organophosphate Dermal Absorption. Toxicol Sci. 2006; 89(1): 188-204.
10. Tsuji JS. Research Strategies for Safety Evaluation of Nanomaterials, Part IV: Risk Assessment of Nanoparticles. Toxicological Sciences. 2005; 89(1): 42-50.